Track topics on Twitter Track topics that are important to you
Shire, a global biotechnology leader in rare diseases, announced the FDA awarded Orphan Drug Designation to Shire’s gene therapy candidate SHP654 (also designated as BAX 888), an investigational factor VIII (FVIII) gene therapy for the treatment of hemophilia A. The regulatory agency also granted Shire investigational new drug (IND) status for SHP654. Orphan Drug Designation […]
The post Shire’s SHP654 receives Orphan Designation for hemophilia A appeared first on CenterWatch News Online.
Original Article: Shire’s SHP654 receives Orphan Designation for hemophilia ANEXT ARTICLE
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...